Clinical Trials Logo

Clinical Trial Summary

- Objective: To analyze the effect of neuromuscular electrostimulation in the maturation of radiocephalic arteriovenous fistula (RC-AVF) patients with chronic kidney disease (CKD) stage 5-5D

- Design: Clinical Trial with medical devices, 18-month, single-center, within the hospital setting.

- Disease or disorder study: vascular Access maturation.

- Population: Patients with CKD stage 5-5D at the research center.

- Project duration: 78 weeks

- Methodology:

- Patients with CKD stages 5-5D that has undergone a native AV in service stations to give their informed consent and meeting the inclusion criteria will be included.

- At baseline two study groups were established:

- Group 1: neuromuscular electrostimulation

- Group 2: isometric exercises


Clinical Trial Description

- Objective: To analyze the effect of neuromuscular electrostimulation in the maturation of radiocephalic arteriovenous fistula (RC-AVF) patients with chronic kidney disease (CKD) stage 5-5D

- Design: Clinical Trial with medical devices, 18-month, single-center, within the hospital setting.

- Disease or disorder study: vascular Access maturation.

- Population: Patients with CKD stage 5-5D at the research center.

- Project duration: 78 weeks

- Methodology:

- Patients with CKD stages 5-5D that has undergone a native AV in service stations to give their informed consent and meeting the inclusion criteria will be included.

- At baseline two study groups were established:

- Group 1: neuromuscular electrostimulation

- Group 2: isometric exercises

- At baseline, patients included in the study the main demographic variables were collected, anthropometric, biochemical parameters, hemodynamic data, Eco Doppler of AV (ECO mapping) and prescribed medical treatment.

- Likewise, they will be made an assessment of their muscle strength by skinfold and upper limb static dynamometry in which was made the native AV.

- During the study period the following phases were established:

• Phase 1 (4 weeks):

- The control group will receive the usual care on an outpatient AV.

- Patients assigned to group, will perform a program of AV electrostimulation in the affected upper extremity (according to program) after 7 days of completion of native AV.

- At the end of this phase both groups were conducted an ECO doppler (ECO4s) AV regulated by Vascular Surgery.

• Phase 2 (8 weeks):

- The control group will receive the usual care on an outpatient AV.

- Patients assigned to group, will perform a program of AV electrostimulation in the affected upper extremity (according to program)

- At the end of this phase, both groups were conducted an ECO doppler (ECO8s) is regulated by the AV Vascular Surgery

- During all phases of the study, patients on hemodialysis follow their analytical controls programmed by Nephrology and receive medical treatment according to standard clinical practice.

- At the end of each phase of the study, all patients were performed an assessment of their muscle strength by centimetría, skinfold thickness and static dynamometry member in which AV has been made.

- Calendar: A provisional timetable is presented

- Presentation of the CEIC study: September 2014

- inclusion Period: 78 weeks

- Follow-up period: 2 months

- Close database: 1 month

- Statistical analysis: 1 month

- Source of funding: Not available ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT02925845
Study type Interventional
Source Hospital de Terrassa
Contact Lucía Inés Martínez Carnovale, MD
Phone +340615950992
Email luciaimartinez@hotmail.com
Status Recruiting
Phase N/A
Start date January 2015
Completion date January 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05302505 - Simulation-based Training for Nurses and Arteriovenous Fistula Puncture in Chronic Hemodialysis Patients N/A
Terminated NCT01642459 - The Outcomes of Arteriovenous Fistula Cannulated From Different Direction. N/A
Recruiting NCT04017806 - Investigating the Role of Luminal Pressure on Arteriovenous Fistula Maturation
Terminated NCT03668002 - Trial of Fistula Versus Graft in Elderly Patients N/A
Completed NCT06199609 - Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula
Recruiting NCT04034433 - Exercise Program for Arteriovenous Fistula Maturation N/A
Active, not recruiting NCT04629118 - Intervention With Selution SLR™ Agent Balloon for Endovascular Latent Limus Therapy for Failing AV Fistulas (ISABELLA) Trial
Recruiting NCT02913365 - Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis N/A
Recruiting NCT05616104 - FLEX FIRST Registry Research Protocol
Recruiting NCT03886116 - Effect of Pre-operative Forearm Exercises on Arterial Venous Fistula Maturation and Blood Flow N/A
Completed NCT02513303 - Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Phase 3
Completed NCT01863914 - Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula Phase 2
Recruiting NCT06001827 - SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study N/A
Recruiting NCT04543539 - IN.PACT™ AV Access Post-Approval Study (PAS002)
Completed NCT05326321 - Effect of Virtual Reality Glasses in The Arteriovenous Fistule Cannulation Processon Paın and Patient Satisfaction N/A
Recruiting NCT03741985 - Effect of Dumbbell Exercise on Arteriovenous Fistula in Patients With Hemodialysis N/A
Terminated NCT03566927 - FLEX®-DCB Dialysis ACCESS Stenosis Study N/A
Not yet recruiting NCT04393688 - Study Evaluating the Safety and Efficacy of Tri-wire Balloon for Treatment of Dysfunctional AV Fistula N/A
Recruiting NCT02447796 - Dexmedetomidine and Propofol As Sole Sedative Agent for Patients Undergoing Arteriovenous Fistula Surgery Phase 4
Terminated NCT01321866 - Cutting Balloon Versus Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients N/A